Intarcia Therapeutics (United States)
Intarcia Therapeutics is an American biopharmaceutical company based in Boston, MA and incorporated under the laws of Delaware. It was founded in 1995 under the name "BioMedicines" and changed to its present name in 2004. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Intarcia Therapeutics (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
59%
Total
Publications
96
Total Open
Publications
57
Total
Citations
4.1K
Open Access
Percentage
59%
Total
Publications
96
Total Open
Publications
57
Total
Citations
4.1K
Breakdown
Publisher Open
19%
Both
28%
Other Platform Open
12%
Closed
41%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 29%
13
Hybrid 40%
18
No Guarantees 31%
14
Other Platform Open
Domain 72%
28
Preprint 26%
10
Institution 21%
8
Other Internet 18%
7
Public 3%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
DOI | Other Internet | 49 |
PubMed Central | Domain | 28 |
bioRxiv | Preprint | 9 |
Europe PMC | Domain | 8 |
University of North Carolina at Chapel Hill - Carolina Digital Repository | Institution | 2 |
University College London - UCL Discovery | Institution | 2 |
The Deutsches Elektronen-Synchrotron - Desy publication database | Institution | 2 |
University of Michigan - Deep Blue | Institution | 1 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 1 |
Indiana University - Purdue University Indianapolis - IUPUI ScholarWorks | Institution | 1 |